Compensatory induction of MYC expression by sustained CDK9 inhibition via a BRD4-dependent mechanism is a research paper published in eLife (2015). On theSindex it has a DataRank of 0.759. It has been cited 157 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.759
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health (NIH)
Grant: R01AI41757
National Institutes of Health (NIH)
Grant: R01AI095057
U.S. Department of Defense
Grant: W81XWH-15-1-0067
U.S. Department of Defense
Grant: W81XWH-15-1-0068
National Natural Science Foundation of China
Grant: 81201276
National Institutes of Health
Grant: 5R01AI041757-07
Regulation of Transcriptional Elongation by HIV-1 TAT
National Institutes of Health
Grant: 1R01AI095057-01
Tat cofactors and control of HIV-1 latency
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Additional file 1 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Additional file 1 of MC180295 is a highly potent and selective CDK9 inhibitor with preclinical in vitro and in vivo efficacy in cancer
Additional file 1 of MC180295 is a highly potent and selective CDK9 inhibitor with preclinical in vitro and in vivo efficacy in cancer
Additional file 7 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Additional file 8 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Additional file 4 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Additional file 5 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Additional file 4 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Additional file 3 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Additional file 2 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Additional file 2 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Additional file 6 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Additional file 7 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Additional file 6 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Additional file 5 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Additional file 8 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Additional file 3 of CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma